Luyi Huang

2.5k total citations · 1 hit paper
45 papers, 1.5k citations indexed

About

Luyi Huang is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Luyi Huang has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Organic Chemistry. Recurrent topics in Luyi Huang's work include Ubiquitin and proteasome pathways (11 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Luyi Huang is often cited by papers focused on Ubiquitin and proteasome pathways (11 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Luyi Huang collaborates with scholars based in China, United Kingdom and United States. Luyi Huang's co-authors include Shengyong Yang, Ni Tang, Kai Wang, Zhirong Zhang, Xun Sun, Yu Fu, Shanshan He, Yao Fu, Qing Lin and Luyao Wang and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Luyi Huang

44 papers receiving 1.5k citations

Hit Papers

Dopamine-loaded blood exosomes targeted to brain for bett... 2018 2026 2020 2023 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease
    2018 446 citations Mengke Qu, Qing Lin et al. Journal of Controlled Release profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luyi Huang China 21 979 415 166 141 127 45 1.5k
Feifei Xu China 24 1.2k 1.2× 352 0.8× 395 2.4× 73 0.5× 121 1.0× 76 1.8k
Gloria Bertoli Italy 25 1.5k 1.6× 1.0k 2.5× 112 0.7× 93 0.7× 115 0.9× 60 2.2k
Xiaonan Zhang Sweden 21 1.2k 1.2× 383 0.9× 224 1.3× 43 0.3× 202 1.6× 65 1.9k
Esther C. Y. Woon United Kingdom 24 1.7k 1.7× 680 1.6× 89 0.5× 61 0.4× 73 0.6× 34 2.3k
Chalet Tan United States 26 1.2k 1.2× 507 1.2× 317 1.9× 58 0.4× 133 1.0× 47 2.3k
Maria Frank-Kamenetsky United States 11 1.9k 1.9× 352 0.8× 224 1.3× 45 0.3× 344 2.7× 16 2.8k
Junhui Chen China 19 642 0.7× 136 0.3× 139 0.8× 155 1.1× 99 0.8× 69 1.3k
Johannes Winkler Austria 24 1.5k 1.5× 453 1.1× 119 0.7× 29 0.2× 61 0.5× 78 2.3k
Jingjie Tang China 19 862 0.9× 307 0.7× 103 0.6× 25 0.2× 148 1.2× 31 1.4k

Countries citing papers authored by Luyi Huang

Since Specialization
Citations

This map shows the geographic impact of Luyi Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luyi Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luyi Huang more than expected).

Fields of papers citing papers by Luyi Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luyi Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luyi Huang. The network helps show where Luyi Huang may publish in the future.

Co-authorship network of co-authors of Luyi Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Luyi Huang. A scholar is included among the top collaborators of Luyi Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luyi Huang. Luyi Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Qiu‐Hong, Fei Xie, Honghua Hu, et al.. (2025). An NAG-Activatable Glow-Type Chemiluminescent Probe for Sensitive and Early Diagnosis of Acute Kidney Injury through Urinalysis. Analytical Chemistry. 97(21). 11269–11278. 3 indexed citations
2.
Zhou, You, Ye Yuan, Hao Zhang, et al.. (2025). Metrnl/C‐KIT Axis Attenuates Early Brain Injury Following Subarachnoid Hemorrhage by Inhibiting Neuronal Ferroptosis. CNS Neuroscience & Therapeutics. 31(2). e70286–e70286. 1 indexed citations
3.
Zhang, Rong, Zhirong Zhang, Shan Li, et al.. (2025). GFAT1 promotes the progression of hepatocellular carcinoma via enhancing the O-GlcNAcylation of VEZF1. Cell Death and Disease. 16(1). 647–647.
4.
5.
Wang, Yumeng, Yu Xing, Wanru Wang, et al.. (2024). Magnolol Inhibits High Fructose-Induced Podocyte Inflammation via Downregulation of TKFC/Sp1/HDAC4/Notch1 Activation. Pharmaceuticals. 17(11). 1416–1416. 1 indexed citations
6.
Yang, Yang, Jia‐Xin Yin, Ni Tang, et al.. (2023). O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner. Signal Transduction and Targeted Therapy. 8(1). 63–63. 96 indexed citations
7.
Li, Cong, Qian Zhang, Luyi Huang, et al.. (2023). Discovery of a Hidden Pocket beneath the NES Groove by Novel Noncovalent CRM1 Inhibitors. Journal of Medicinal Chemistry. 66(24). 17044–17058. 4 indexed citations
8.
Wang, Qiujie, Fan Yang, Rui Liu, et al.. (2023). Signaling metabolite succinylacetone activates HIF-1α and promotes angiogenesis in GSTZ1-deficient hepatocellular carcinoma. JCI Insight. 8(23). 8 indexed citations
9.
Jiang, Rong, Jin Xiang, Peng Zhou, et al.. (2023). Identification of a diketopiperazine‐based O‐GlcNAc transferase inhibitor sensitizing hepatocellular carcinoma to CDK9 inhibition. FEBS Journal. 290(18). 4543–4561. 5 indexed citations
10.
Li, Zhi, Jieli Hu, Yuan Hu, et al.. (2023). Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice. European Journal of Medicinal Chemistry. 249. 115141–115141. 6 indexed citations
11.
Sha, Yu, Liangjun Qiao, Dina Liu, et al.. (2023). PLEKHG5 is stabilized by HDAC2-related deacetylation and confers sorafenib resistance in hepatocellular carcinoma. Cell Death Discovery. 9(1). 176–176. 9 indexed citations
12.
Zhou, Peng, Wen‐Yi Chang, Luyi Huang, et al.. (2023). O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma. Oncogene. 42(10). 725–736. 17 indexed citations
13.
Wu, Xiaohong, Chang Chen, Kai Wang, et al.. (2023). SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase. Cell Death and Disease. 14(1). 22–22. 58 indexed citations
14.
Wan, Xueying, Liping Yang, Yilu Qin, et al.. (2023). RGCC-mediated PLK1 activity drives breast cancer lung metastasis by phosphorylating AMPKα2 to activate oxidative phosphorylation and fatty acid oxidation. Journal of Experimental & Clinical Cancer Research. 42(1). 342–342. 23 indexed citations
15.
Yang, Yang, Jie Hu, Xue-Fei Cai, et al.. (2022). Structure-Based Discovery of N-Sulfonylpiperidine-3-Carboxamides as Novel Capsid Assembly Modulators for Potent Inhibition of HBV Replication. Viruses. 14(2). 348–348. 7 indexed citations
16.
Xiao, Peihong, Ke Ma, Miaomiao Kang, et al.. (2021). An aggregation-induced emission platform for efficient Golgi apparatus and endoplasmic reticulum specific imaging. Chemical Science. 12(41). 13949–13957. 28 indexed citations
17.
Jin, Xiang, Chang Chen, Rui Liu, et al.. (2021). Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation. Journal of Clinical Investigation. 131(8). 85 indexed citations
18.
Wang, Kai, Quanxin Long, Haijun Deng, et al.. (2020). Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Clinical Infectious Diseases. 73(3). e531–e539. 130 indexed citations
19.
20.
Qu, Mengke, Qing Lin, Luyi Huang, et al.. (2018). Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease. Journal of Controlled Release. 287. 156–166. 446 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feifei Xu Breakdown of academic impact, for papers by Gloria Bertoli Breakdown of academic impact, for papers by Xiaonan Zhang Breakdown of academic impact, for papers by Esther C. Y. Woon Breakdown of academic impact, for papers by Chalet Tan Breakdown of academic impact, for papers by Maria Frank-Kamenetsky Breakdown of academic impact, for papers by Junhui Chen Breakdown of academic impact, for papers by Johannes Winkler Breakdown of academic impact, for papers by Jingjie Tang
Rankless by CCL
2026